These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 26763403)
1. Detection of metabolic activation leading to drug-induced phospholipidosis in rat hepatocyte spheroids. Takagi M; Sanoh S; Santoh M; Ejiri Y; Kotake Y; Ohta S J Toxicol Sci; 2016 Feb; 41(1):155-64. PubMed ID: 26763403 [TBL] [Abstract][Full Text] [Related]
2. Phospholipidosis assay in HepG2 cells and rat or rhesus hepatocytes using phospholipid probe NBD-PE. Bhandari N; Figueroa DJ; Lawrence JW; Gerhold DL Assay Drug Dev Technol; 2008 Jun; 6(3):407-19. PubMed ID: 18537465 [TBL] [Abstract][Full Text] [Related]
3. A cell-based assay using HepaRG cells for predicting drug-induced phospholipidosis. Tomida T; Ishimura M; Iwaki M J Toxicol Sci; 2017; 42(5):641-650. PubMed ID: 28904299 [TBL] [Abstract][Full Text] [Related]
4. Validation of an in vitro screen for phospholipidosis using a high-content biology platform. Morelli JK; Buehrle M; Pognan F; Barone LR; Fieles W; Ciaccio PJ Cell Biol Toxicol; 2006 Jan; 22(1):15-27. PubMed ID: 16463016 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the phospholipidogenic potential of 4(1H)-pyridone antimalarial derivatives. Almela MJ; Torres PA; Lozano S; Herreros E Toxicol In Vitro; 2009 Dec; 23(8):1528-34. PubMed ID: 19540329 [TBL] [Abstract][Full Text] [Related]
6. Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats. Miyamoto S; Matsumoto A; Mori I; Horinouchi A Toxicol Mech Methods; 2009 Oct; 19(8):477-85. PubMed ID: 19793005 [TBL] [Abstract][Full Text] [Related]
7. Hepatocyte spheroids as a viable Chacko SA; Ly VT; Christopher LJ; Gan J Xenobiotica; 2020 Jun; 50(6):621-629. PubMed ID: 31566996 [TBL] [Abstract][Full Text] [Related]
8. Detection of nanocarrier potentiation on drug induced phospholipidosis in cultured cells and primary hepatocyte spheroids by high content imaging and analysis. Zhang X; Yang L; Liu Y; Song Z; Zhao J; Chen D; Yu H; Li R; Wang Y; Yang K; Chen Y; Xia M; Zhang LW Toxicol Appl Pharmacol; 2018 Jun; 348():54-66. PubMed ID: 29678448 [TBL] [Abstract][Full Text] [Related]
9. Fluorometric assessment of acetaminophen-induced toxicity in rat hepatocyte spheroids seeded on micro-space cell culture plates. Sanoh S; Santoh M; Takagi M; Kanayama T; Sugihara K; Kotake Y; Ejiri Y; Horie T; Kitamura S; Ohta S Toxicol In Vitro; 2014 Sep; 28(6):1176-82. PubMed ID: 24878114 [TBL] [Abstract][Full Text] [Related]
10. In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies. Nioi P; Perry BK; Wang EJ; Gu YZ; Snyder RD Toxicol Sci; 2007 Sep; 99(1):162-73. PubMed ID: 17567588 [TBL] [Abstract][Full Text] [Related]
11. From the Cover: Potentiation of Drug-Induced Phospholipidosis In Vitro through PEGlyated Graphene Oxide as the Nanocarrier. Yang L; Zhong X; Li Q; Zhang X; Wang Y; Yang K; Zhang LW Toxicol Sci; 2017 Mar; 156(1):39-53. PubMed ID: 28013220 [TBL] [Abstract][Full Text] [Related]
12. High content screening analysis of phospholipidosis: validation of a 96-well assay with CHO-K1 and HepG2 cells for the prediction of in vivo based phospholipidosis. van de Water FM; Havinga J; Ravesloot WT; Horbach GJ; Schoonen WG Toxicol In Vitro; 2011 Dec; 25(8):1870-82. PubMed ID: 21651975 [TBL] [Abstract][Full Text] [Related]
13. Spheroid-based three-dimensional liver-on-a-chip to investigate hepatocyte-hepatic stellate cell interactions and flow effects. Lee SA; No da Y; Kang E; Ju J; Kim DS; Lee SH Lab Chip; 2013 Sep; 13(18):3529-37. PubMed ID: 23657720 [TBL] [Abstract][Full Text] [Related]
14. Cell-based fluorescence assay for evaluation of new-drugs potential for phospholipidosis in an early stage of drug development. Fujimura H; Dekura E; Kurabe M; Shimazu N; Koitabashi M; Toriumi W Exp Toxicol Pathol; 2007 Aug; 58(6):375-82. PubMed ID: 17408938 [TBL] [Abstract][Full Text] [Related]
15. Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing. Tostões RM; Leite SB; Serra M; Jensen J; Björquist P; Carrondo MJ; Brito C; Alves PM Hepatology; 2012 Apr; 55(4):1227-36. PubMed ID: 22031499 [TBL] [Abstract][Full Text] [Related]
16. Adaptation of an in vitro phospholipidosis assay to an automated image analysis system. Schurdak ME; Vernetti LA; Abel SJ; Thiffault C Toxicol Mech Methods; 2007; 17(2):77-86. PubMed ID: 20020975 [TBL] [Abstract][Full Text] [Related]
17. Identification of hepatic phospholipidosis inducers in sandwich-cultured rat hepatocytes, a physiologically relevant model, reveals altered basolateral uptake and biliary excretion of anionic probe substrates. Ferslew BC; Brouwer KL Toxicol Sci; 2014 May; 139(1):99-107. PubMed ID: 24563379 [TBL] [Abstract][Full Text] [Related]
18. Mixed-ligand modification of polyamidoamine dendrimers to develop an effective scaffold for maintenance of hepatocyte spheroids. Higashiyama S; Noda M; Kawase M; Yagi K J Biomed Mater Res A; 2003 Mar; 64(3):475-82. PubMed ID: 12579561 [TBL] [Abstract][Full Text] [Related]
19. Evaluating the risk of phospholipidosis using a new multidisciplinary pipeline approach. Goracci L; Buratta S; Urbanelli L; Ferrara G; Di Guida R; Emiliani C; Cross S Eur J Med Chem; 2015 Mar; 92():49-63. PubMed ID: 25544686 [TBL] [Abstract][Full Text] [Related]
20. In vitro validation of drug-induced phospholipidosis. Park S; Choi YJ; Lee BH J Toxicol Sci; 2012; 37(2):261-7. PubMed ID: 22467016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]